Rapport Therapeutics RAPP
NASDAQ RAPP
$33.60 +0.58 (+1.76%)
At close: Sep 30, 2026 · 4:00 PM EDT

Rapport Therapeutics (RAPP) Other financing activities (2024 - 2026)

Updated

Rapport Therapeutics' Other financing activities was $181,000 in Q2 2026, up 187.3% from $63,000 a year earlier but down 33.7% from the prior quarter.

Analysis

Rapport Therapeutics (RAPP) Other financing activities (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Rapport Therapeutics' Other financing activities was $517,000 through Jun 30, 2026; for FY2023, it came in at $134,000.

  • Quarterly Other financing activities has moved between $63,000 (Q2 2025) and $283,000 (Q1 2024) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Rapport Therapeutics 1.61 Bn 1.61 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 181,000.00
Mar 31, 2026 273,000.00
Jun 30, 2025 63,000.00
Mar 31, 2024 283,000.00
API Access

Rapport Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=RAPP&period=max&api_key=YOUR_API_KEY